CN111551745A - 禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 - Google Patents
禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 Download PDFInfo
- Publication number
- CN111551745A CN111551745A CN202010410001.9A CN202010410001A CN111551745A CN 111551745 A CN111551745 A CN 111551745A CN 202010410001 A CN202010410001 A CN 202010410001A CN 111551745 A CN111551745 A CN 111551745A
- Authority
- CN
- China
- Prior art keywords
- colloidal gold
- test paper
- subtype
- pad
- avian influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 77
- 241000342557 H7N9 subtype Species 0.000 title claims abstract description 62
- 238000012360 testing method Methods 0.000 title claims abstract description 56
- 241000712461 unidentified influenza virus Species 0.000 title claims abstract description 46
- 101710141454 Nucleoprotein Proteins 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000001514 detection method Methods 0.000 claims abstract description 59
- 239000012528 membrane Substances 0.000 claims abstract description 39
- 102000036639 antigens Human genes 0.000 claims abstract description 36
- 108091007433 antigens Proteins 0.000 claims abstract description 36
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 35
- 239000000427 antigen Substances 0.000 claims abstract description 33
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 24
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 24
- 238000003908 quality control method Methods 0.000 claims abstract description 22
- 241000283707 Capra Species 0.000 claims abstract description 11
- 238000010521 absorption reaction Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 12
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 12
- 239000004800 polyvinyl chloride Substances 0.000 claims description 12
- 238000005507 spraying Methods 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 10
- 239000001509 sodium citrate Substances 0.000 claims description 9
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 9
- 229940038773 trisodium citrate Drugs 0.000 claims description 9
- 239000007983 Tris buffer Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000001042 affinity chromatography Methods 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- ILXAOQAXSHVHTM-UHFFFAOYSA-M sodium;2-amino-2-(hydroxymethyl)propane-1,3-diol;chloride Chemical compound [Na+].[Cl-].OCC(N)(CO)CO ILXAOQAXSHVHTM-UHFFFAOYSA-M 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000002965 ELISA Methods 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 208000002979 Influenza in Birds Diseases 0.000 description 6
- 206010064097 avian influenza Diseases 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000005457 optimization Methods 0.000 description 5
- 241000712431 Influenza A virus Species 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 101710154606 Hemagglutinin Proteins 0.000 description 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 3
- 101710176177 Protein A56 Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000185 hemagglutinin Substances 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010022004 Influenza like illness Diseases 0.000 description 1
- 208000003898 Mediastinal Emphysema Diseases 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 206010050184 Pneumomediastinum Diseases 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
样品浓度 | 50ng/ml | 100ng/ml | 200ng/ml | 400ng/ml | 800ng/ml | 空白 |
实施例1 | 阳性(色浅) | 阳性(色浅) | 阳性(正常) | 阳性(正常) | 阳性(色深) | 阴性 |
实施例2 | 阴性(无线) | 阳性(色浅) | 阳性(色浅) | 阳性(正常) | 阳性(正常) | 阴性 |
实施例3 | 阴性(无线) | 阳性(色浅) | 阳性(色浅) | 阳性(正常) | 阳性(正常) | 阴性 |
试验例1 | 阴性(无线) | 阳性(色浅) | 阳性(色浅) | 阳性(正常) | 阳性(色深) | 阴性 |
试验例2 | 阴性(无线) | 阳性(色浅) | 阳性(色浅) | 阳性(正常) | 阳性(色深) | 阴性 |
ELISA | 阳性 | 阳性 | 阳性 | 阳性 | 阳性 | 阴性 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010410001.9A CN111551745B (zh) | 2020-05-15 | 2020-05-15 | 禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010410001.9A CN111551745B (zh) | 2020-05-15 | 2020-05-15 | 禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111551745A true CN111551745A (zh) | 2020-08-18 |
CN111551745B CN111551745B (zh) | 2023-04-07 |
Family
ID=72002768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010410001.9A Active CN111551745B (zh) | 2020-05-15 | 2020-05-15 | 禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111551745B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114062671A (zh) * | 2021-09-22 | 2022-02-18 | 中国科学院大学 | 一种新型冠状病毒抗体检测试纸、制备方法和应用 |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007068154A1 (en) * | 2005-10-31 | 2007-06-21 | Jason Medical Group (Far East) Ltd | A method for preparing specific igy against mutant avian influenza virus and the preparation tηereof |
CN101012445A (zh) * | 2007-01-31 | 2007-08-08 | 华中农业大学 | 一种鸡禽流感疫苗免疫与病毒野毒感染的胶体金免疫层析快速鉴别诊断试剂盒及应用 |
CN101348777A (zh) * | 2008-07-25 | 2009-01-21 | 中国农业大学 | A型流感病毒核蛋白捕获elisa抗原诊断试剂盒及专用单克隆抗体 |
CN103450350A (zh) * | 2013-07-30 | 2013-12-18 | 中国人民解放军军事医学科学院基础医学研究所 | 人感染h7n9禽流感表位抗原及其在免疫检测试剂中的用途 |
CN104237537A (zh) * | 2014-10-21 | 2014-12-24 | 南京基蛋生物科技有限公司 | 一种检测心肌肌钙蛋白的免疫层析荧光试剂条及制备方法 |
CN105334319A (zh) * | 2015-10-21 | 2016-02-17 | 黑龙江省乳品工业技术开发中心 | 一种检测乳中玉米赤霉烯酮的试纸条 |
CN105445459A (zh) * | 2015-12-01 | 2016-03-30 | 浙江普康生物技术股份有限公司 | 一种检测h7n9亚型禽流感病毒神经氨酸酶特异性抗体的多肽-酶联免疫吸附试剂盒 |
CN105548541A (zh) * | 2016-01-11 | 2016-05-04 | 王好玉 | 一种禽流感病毒检测试剂盒 |
RU2587629C1 (ru) * | 2014-12-29 | 2016-06-20 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Реассортантный штамм вируса гриппа rn9/13-human a(h6n9) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации |
CN105974114A (zh) * | 2016-07-06 | 2016-09-28 | 聊城大学 | 一种检测鸡禽流感的纳米金免疫层析试纸及应用 |
CN107064499A (zh) * | 2017-03-15 | 2017-08-18 | 青岛蔚蓝生物制品有限公司 | 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒 |
CN107344968A (zh) * | 2016-05-04 | 2017-11-14 | 广州优迪生物科技有限公司 | 一种用于检测禽流感病毒h7n9的时间分辨荧光免疫分析方法 |
KR101835682B1 (ko) * | 2016-11-18 | 2018-03-07 | 원광대학교산학협력단 | H7 아형 인플루엔자 바이러스의 헤마글루티닌에 특이적인 단클론항체 및 이를 이용한 신속 형광면역 진단키트 |
CN108303529A (zh) * | 2018-01-23 | 2018-07-20 | 武汉科前生物股份有限公司 | 一种用于检测禽流感病毒h7亚型的免疫胶体金试纸条及其制备方法 |
CN109142725A (zh) * | 2018-08-29 | 2019-01-04 | 陕西省人民医院 | 一种甲型通用及h7n9亚型流感病毒胶体金联合检测试纸的制备方法 |
CN109609538A (zh) * | 2017-06-16 | 2019-04-12 | 西南交通大学 | 一种预防h7n9病毒感染的口服疫苗及其制备方法 |
CN208752087U (zh) * | 2018-06-01 | 2019-04-16 | 常州博闻迪医药股份有限公司 | 一种定量检测三种心脏标志物的荧光免疫层析检测试剂盒 |
CN109900913A (zh) * | 2019-04-26 | 2019-06-18 | 江苏硕世生物科技股份有限公司 | 一种甲型和乙型流感病毒抗原胶体金法联合检测试剂盒及其制备方法 |
CN109975544A (zh) * | 2019-04-26 | 2019-07-05 | 安徽荣达生物技术有限公司 | 一种PEDV IgY抗体胶体金检测试纸条及其制备方法和应用 |
WO2019147891A1 (en) * | 2018-01-26 | 2019-08-01 | Children's Hospital Medical Center | Compositions and methods for determining avian influenza virus susceptabilty |
CN110702927A (zh) * | 2019-11-04 | 2020-01-17 | 南京欧凯生物科技有限公司 | 用于检测抗缪勒氏管激素的胶体金免疫层析试纸条及其制备方法 |
-
2020
- 2020-05-15 CN CN202010410001.9A patent/CN111551745B/zh active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007068154A1 (en) * | 2005-10-31 | 2007-06-21 | Jason Medical Group (Far East) Ltd | A method for preparing specific igy against mutant avian influenza virus and the preparation tηereof |
CN101012445A (zh) * | 2007-01-31 | 2007-08-08 | 华中农业大学 | 一种鸡禽流感疫苗免疫与病毒野毒感染的胶体金免疫层析快速鉴别诊断试剂盒及应用 |
CN101348777A (zh) * | 2008-07-25 | 2009-01-21 | 中国农业大学 | A型流感病毒核蛋白捕获elisa抗原诊断试剂盒及专用单克隆抗体 |
CN103450350A (zh) * | 2013-07-30 | 2013-12-18 | 中国人民解放军军事医学科学院基础医学研究所 | 人感染h7n9禽流感表位抗原及其在免疫检测试剂中的用途 |
CN104237537A (zh) * | 2014-10-21 | 2014-12-24 | 南京基蛋生物科技有限公司 | 一种检测心肌肌钙蛋白的免疫层析荧光试剂条及制备方法 |
RU2587629C1 (ru) * | 2014-12-29 | 2016-06-20 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Реассортантный штамм вируса гриппа rn9/13-human a(h6n9) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации |
CN105334319A (zh) * | 2015-10-21 | 2016-02-17 | 黑龙江省乳品工业技术开发中心 | 一种检测乳中玉米赤霉烯酮的试纸条 |
CN105445459A (zh) * | 2015-12-01 | 2016-03-30 | 浙江普康生物技术股份有限公司 | 一种检测h7n9亚型禽流感病毒神经氨酸酶特异性抗体的多肽-酶联免疫吸附试剂盒 |
CN105548541A (zh) * | 2016-01-11 | 2016-05-04 | 王好玉 | 一种禽流感病毒检测试剂盒 |
CN107344968A (zh) * | 2016-05-04 | 2017-11-14 | 广州优迪生物科技有限公司 | 一种用于检测禽流感病毒h7n9的时间分辨荧光免疫分析方法 |
CN105974114A (zh) * | 2016-07-06 | 2016-09-28 | 聊城大学 | 一种检测鸡禽流感的纳米金免疫层析试纸及应用 |
KR101835682B1 (ko) * | 2016-11-18 | 2018-03-07 | 원광대학교산학협력단 | H7 아형 인플루엔자 바이러스의 헤마글루티닌에 특이적인 단클론항체 및 이를 이용한 신속 형광면역 진단키트 |
CN107064499A (zh) * | 2017-03-15 | 2017-08-18 | 青岛蔚蓝生物制品有限公司 | 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒 |
CN109609538A (zh) * | 2017-06-16 | 2019-04-12 | 西南交通大学 | 一种预防h7n9病毒感染的口服疫苗及其制备方法 |
CN108303529A (zh) * | 2018-01-23 | 2018-07-20 | 武汉科前生物股份有限公司 | 一种用于检测禽流感病毒h7亚型的免疫胶体金试纸条及其制备方法 |
WO2019147891A1 (en) * | 2018-01-26 | 2019-08-01 | Children's Hospital Medical Center | Compositions and methods for determining avian influenza virus susceptabilty |
CN208752087U (zh) * | 2018-06-01 | 2019-04-16 | 常州博闻迪医药股份有限公司 | 一种定量检测三种心脏标志物的荧光免疫层析检测试剂盒 |
CN109142725A (zh) * | 2018-08-29 | 2019-01-04 | 陕西省人民医院 | 一种甲型通用及h7n9亚型流感病毒胶体金联合检测试纸的制备方法 |
CN109900913A (zh) * | 2019-04-26 | 2019-06-18 | 江苏硕世生物科技股份有限公司 | 一种甲型和乙型流感病毒抗原胶体金法联合检测试剂盒及其制备方法 |
CN109975544A (zh) * | 2019-04-26 | 2019-07-05 | 安徽荣达生物技术有限公司 | 一种PEDV IgY抗体胶体金检测试纸条及其制备方法和应用 |
CN110702927A (zh) * | 2019-11-04 | 2020-01-17 | 南京欧凯生物科技有限公司 | 用于检测抗缪勒氏管激素的胶体金免疫层析试纸条及其制备方法 |
Non-Patent Citations (2)
Title |
---|
仇书兴等: "新型H7N9禽流感病毒NA蛋白胞外区片段的生物信息学分析及其多克隆抗体制备", 《生物技术通报》 * |
单虎等: "《现代兽医兽药大全 动物生物制品分册》", 30 April 2011 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114062671A (zh) * | 2021-09-22 | 2022-02-18 | 中国科学院大学 | 一种新型冠状病毒抗体检测试纸、制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN111551745B (zh) | 2023-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2063270B1 (en) | Rapid diagnosis method specific to avian influenza virus | |
CN101470116B (zh) | 检测禽流感病毒的胶体金免疫渗滤增敏方法及其试剂盒 | |
CN111983217B (zh) | 一种样本处理液及其应用 | |
CN114594262B (zh) | 基于双功能融合蛋白的真菌毒素磁化学发光免疫分析试剂盒及其应用 | |
CN112940114B (zh) | 一种抗真菌1,3-β-D-葡聚糖单克隆抗体及其应用 | |
CN113321715B (zh) | 新型冠状病毒抗原及其检测用途 | |
CN111551745B (zh) | 禽流感病毒H7N9亚型N蛋白IgY抗体检测胶体金试纸及方法 | |
CN113087779A (zh) | 一种马尔尼菲篮状菌甘露糖蛋白、抗体、检测试剂及试剂盒 | |
CN110568177B (zh) | 一种寨卡病毒e抗原及其在荧光免疫层析试剂中的应用 | |
CN111551746A (zh) | 非洲猪瘟病毒N蛋白IgY抗体检测胶体金试纸及方法 | |
CN111537483B (zh) | 检测冈田酸的荧光核酸适配体传感器、其制备方法与使用该传感器检测冈田酸的方法 | |
CN111579792B (zh) | 流感病毒和2019新型冠状病毒抗体联合检测装置及其制备方法 | |
CN113203856A (zh) | 检测冠状病毒抗体的试剂盒、冠状病毒抗体的检测方法 | |
CN104744590B (zh) | 抗甲型h1n1猪流感病毒血凝素蛋白单克隆抗体及双抗夹心elisa试剂盒 | |
CN104297494B (zh) | 一种抗乙型肝炎病毒x蛋白抗体酶联免疫测定试剂盒及其制备方法 | |
CN114778852B (zh) | 一种检测prrsv plp2抗体的间接elisa方法 | |
Li et al. | Development and application of a novel triplex protein microarray method for rapid detection of antibodies against avian influenza virus, Newcastle disease virus, and avian infectious bronchitis virus | |
CN112698032A (zh) | 一种新型冠状病毒s抗原胶体金标记工艺及其应用 | |
Ma et al. | A chemiluminescence immunoassay for rapid detection of classical swine fever virus E2 antibodies in pig serum samples | |
CN211122896U (zh) | 一种新城疫病毒抗体磁免疫化学发光检测试剂盒 | |
Imani Gheshlaghchaei et al. | Development of a Nano-ELISA system for the rapid and sensitive detection of H9N2 avian influenza | |
CN109613239B (zh) | A群轮状病毒检测试纸 | |
CN118376777A (zh) | 一种基于管式化学发光技术的猪伪狂犬病毒gB蛋白抗体检测试剂盒 | |
CN111551744A (zh) | 新城疫病毒N蛋白IgY抗体胶体碳检测试纸及其应用 | |
CN103849630A (zh) | 一种重组人细小病毒b19蛋白及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240319 Address after: No. 3, 4th Floor, Unit 2, Building 2, No. 1699 Shanghong Road, Weiyang District, Xi'an City, Shaanxi Province, 710016 Patentee after: Zhao Xiaofeng Country or region after: China Patentee after: Wang Shunming Address before: 230000 room 678, block B, 88 Lanzhou Road, economic development zone, Baohe District, Hefei City, Anhui Province Patentee before: Anhui Zhongqi Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240403 Address after: 710000, Room 11203, Building 2, No. 220 Zhonggang International, Middle Section of Wenjing Road, Xi'an Economic and Technological Development Zone, Shaanxi Province Patentee after: Xi'an Fumeilai Agriculture and Animal Husbandry Technology Co.,Ltd. Country or region after: China Address before: No. 3, 4th Floor, Unit 2, Building 2, No. 1699 Shanghong Road, Weiyang District, Xi'an City, Shaanxi Province, 710016 Patentee before: Zhao Xiaofeng Country or region before: China Patentee before: Wang Shunming |
|
TR01 | Transfer of patent right |